# A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age

> **NCT00946101** · PHASE4 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 326 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** MEDI3414 [Influenza A(H1N1) live attenuated, intranasal]
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00946101
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-09
- **Final completion:** 2010-03
- **Target enrollment:** 326 (ACTUAL)
- **Last updated:** 2011-08-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00946101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00946101, "A Study to Evaluate the Safety of HIN1 Monovalent Vaccine (MEDI3414) in Children 2 to 17 Years of Age". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00946101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*